Delhi High Court cancels OTRINIR registration, holds it similar to OTRIVIN
The note discusses the cancellation petition filed by GSK Consumer Healthcare SA (GSK) against the Respondent Celebrity Biopharma’s (Celebrity) registration for the mark OTRINIR. GSK sought cancellation based on their prior adoption and use of the mark OTRIVIN. While deciding the case, the Delhi High Court has discussed in detail the Anti-dissection and common-to-trade rule…